FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:1494-1499 May 24, 1990 Number 21 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Familial hypercholesterolemia carries a marked increase in the risk of coronary heart disease (CHD), but there is considerable variation between individuals in susceptibility to CHD. To investigate the possible role of lipoprotein(a) as a risk factor for CHD, we studied the association between serum lipoprotein(a) levels, genetic types of apolipoprotein(a) (which influence lipoprotein(a) levels), and CHD in 115 patients with heterozygous familial hypercholesterolemia. The median lipoprotein(a) level in the 54 patients with CHD was 57 mg per deciliter, which is significantly higher than the corresponding value of 18 mg per deciliter in the 61 patients without CHD. According to discriminant-function analysis, the lipoprotein(a) level was the best discriminator between the two groups (as compared with all other lipid and lipoprotein levels, age, sex, and smoking status). Phenotyping for apolipoprotein(a) was performed in 109 patients. The frequencies of the apolipoprotein(a) phenotypes and alleles differed significantly between the patients with and those without CHD. The allele LpS2, which is associated with high lipoprotein(a) levels, was found more frequently among the patients with CHD (0.33 vs. 0.12). In contrast, the LpS4 allele, which is associated with low lipoprotein(a) levels, was more frequent among those without CHD (0.27 vs. 0.15). We conclude that an elevated level of lipoprotein(a) is a strong risk factor for CHD in patients with familial hypercholesterolemia, and the increase in risk is independent of age, sex, smoking status, and serum levels of total cholesterol, triglyceride, or high-density lipoprotein cholesterol. The higher level of lipoprotein(a) observed in the patients with CHD is the result of genetic influence.

Source Information

Department of Medicine, Charing Cross and Westminister Medical School, London, United Kingdom.

This article has been cited by other articles:

• Holmes, D. T., Schick, B. A., Humphries, K. H., Frohlich, J. (2005). Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia. Clin. Chem. 51: 2067-2073 [Abstract] [Full Text]  
• Knoll, G. A., Wells, P. S., Young, D., Perkins, S. L., Pilkey, R. M., Clinch, J. J., Rodger, M. A. (2005). Thrombophilia and the Risk for Hemodialysis Vascular Access Thrombosis. J. Am. Soc. Nephrol. 16: 1108-1114 [Abstract] [Full Text]  
• Neil, H A W, Seagroatt, V, Betteridge, D J, Cooper, M P, Durrington, P N, Miller, J P, Seed, M, Naoumova, R P, Thompson, G R, Huxley, R, Humphries, S E (2004). Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart 90: 1431-1437 [Abstract] [Full Text]  
• Berglund, L., Ramakrishnan, R. (2004). Lipoprotein(a): An Elusive Cardiovascular Risk Factor. Arterioscler. Thromb. Vasc. Bio. 24: 2219-2226 [Abstract] [Full Text]  
• Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., Marcovina, S. M. (2004). Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study. Clin. Chem. 50: 1364-1371 [Abstract] [Full Text]  
• Slyper, A. H. (2004). What Vascular Ultrasound Testing Has Revealed about Pediatric Atherogenesis, and a Potential Clinical Role for Ultrasound in Pediatric Risk Assessment. J. Clin. Endocrinol. Metab. 89: 3089-3095 [Abstract] [Full Text]  
• Muller, H., Lindman, A. S., Blomfeldt, A., Seljeflot, I., Pedersen, J. I. (2003). A Diet Rich in Coconut Oil Reduces Diurnal Postprandial Variations in Circulating Tissue Plasminogen Activator Antigen and Fasting Lipoprotein (a) Compared with a Diet Rich in Unsaturated Fat in Women. J. Nutr. 133: 3422-3427 [Abstract] [Full Text]  
• Sun, H., Unoki, H., Wang, X., Liang, J., Ichikawa, T., Arai, Y., Shiomi, M., Marcovina, S. M., Watanabe, T., Fan, J. (2002). Lipoprotein(a) Enhances Advanced Atherosclerosis and Vascular Calcification in WHHL Transgenic Rabbits Expressing Human Apolipoprotein(a). J. Biol. Chem. 277: 47486-47492 [Abstract] [Full Text]  
• Kang, C., Dominguez, M., Loyau, S., Miyata, T., Durlach, V., Angles-Cano, E. (2002). Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner: A Study With Different-Length Recombinant Apo(a), Native Lp(a), and Monoclonal Antibody. Arterioscler. Thromb. Vasc. Bio. 22: 1232-1238 [Abstract] [Full Text]  
• Braunstein, J. B., Kershner, D. W., Bray, P., Gerstenblith, G., Schulman, S. P., Post, W. S., Blumenthal, R. S. (2002). Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest 121: 906-920 [Abstract] [Full Text]  
• Rubin, J., Paultre, F., Tuck, C. H., Holleran, S., Reed, R. G., Pearson, T. A., Thomas, C. M., Ramakrishnan, R., Berglund, L. (2002). Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians. J. Lipid Res. 43: 234-244 [Abstract] [Full Text]  
• Ichikawa, T., Unoki, H., Sun, H., Shimoyamada, H., Marcovina, S., Shikama, H., Watanabe, T., Fan, J. (2002). Lipoprotein(a) Promotes Smooth Muscle Cell Proliferation and Dedifferentiation in Atherosclerotic Lesions of Human Apo(a) Transgenic Rabbits. Am. J. Pathol. 160: 227-236 [Abstract] [Full Text]  
• Sijbrands, E. J G, Westendorp, R. G J, Defesche, J. C, de Meier, P. H E M, Smelt, A. H M, Kastelein, J. J P, Kaprio, J. (2001). Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease. BMJ 322: 1019-1023 [Abstract] [Full Text]  
• Real, J.T, Chaves, F.J, Martinez-Uso, I, Garcia-Garcia, A.B, Ascaso, J.F, Carmena, R (2001). Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Eur Heart J 22: 465-471 [Abstract]  
• von Eckardstein, A., Schulte, H., Cullen, P., Assmann, G. (2001). Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 37: 434-439 [Abstract] [Full Text]  
• Fan, J., Shimoyamada, H., Sun, H., Marcovina, S., Honda, K., Watanabe, T. (2001). Transgenic Rabbits Expressing Human Apolipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-Rich Diet. Arterioscler. Thromb. Vasc. Bio. 21: 88-94 [Abstract] [Full Text]  
• Bhatnagar, D, Morgan, J, Siddiq, S, Mackness, M I, Miller, J P, Durrington, P N (2000). Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ 321: 1497-1497 [Abstract] [Full Text]  
• Bjorn Lundahl, , Leren, T. P., Ose, L., Hamsten, A., Karpe, F. (2000). A Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein (MTP -493G/T) Influences Lipoprotein Phenotype in Familial Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 20: 1784-1788 [Abstract] [Full Text]  
• Fan, J., Challah, M., Shimoyamada, H., Shiomi, M., Marcovina, S., Watanabe, T. (2000). Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]. J. Lipid Res. 41: 1004-1012 [Abstract] [Full Text]  
• Meier, P., Blanc, E. (2000). Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia. Nephrol Dial Transplant 15: 738-740 [Full Text]  
• Akosah, K. O., Gower, E., Groon, L., Rooney, B. L., Schaper, A. (2000). Mild hypercholesterolemia and premature heart disease: do the national criteria underestimate disease risk?. J Am Coll Cardiol 35: 1178-1184 [Abstract] [Full Text]  
• Wierzbicki, A. (2000). Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Lupus 9: 194-201 [Abstract]  
• Kraft, H. G., Lingenhel, A., Raal, F. J., Hohenegger, M., Utermann, G. (2000). Lipoprotein(a) in Homozygous Familial Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 20: 522-528 [Abstract] [Full Text]  
• Gazzaruso, C., Garzaniti, A., Buscaglia, P., Bonetti, G., Falcone, C., Fratino, P., Finardi, G., Geroldi, D. (1999). Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. J Am Coll Cardiol 33: 157-163 [Abstract] [Full Text]  
• O'Malley, J. P., BS, J. P., Maslen, C. L., Illingworth, D. R. (1998). Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia. Circulation 97: 1780-1783 [Abstract] [Full Text]  
• Couderc, R., Peoc'h, K., Valenti, K., Diop, M-E., Bailleul, S., Kienou, L., Ferriere, F., Etienne, J. (1998). A Simple Electrophoretic Method for Phenotyping Apo(a): Phenotype Frequency in Healthy Subjects from Paris, France. Clin. Chem. 44: 1047-1050 [Full Text]  
• Espeland, M. A., Marcovina, S. M., Miller, V., Wood, P. D., Wasilauskas, C., Sherwin, R., Schrott, H., Bush, T. L. (1998). Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration. Circulation 97: 979-986 [Abstract] [Full Text]  
• Wittekoek, M. E., Pimstone, S. N., Reymer, P. W. A., Feuth, L., Botma, G.-J., Defesche, J. C., Prins, M., Hayden, M. R., Kastelein, J. J. P. (1998). A Common Mutation in the Lipoprotein Lipase Gene (N291S) Alters the Lipoprotein Phenotype and Risk for Cardiovascular Disease in Patients With Familial Hypercholesterolemia. Circulation 97: 729-735 [Abstract] [Full Text]  
• Pimstone, S. N., Sun, X.-M., du Souich, C., Frohlich, J. J., Hayden, M. R., Soutar, A. K. (1998). Phenotypic Variation in Heterozygous Familial Hypercholesterolemia : A Comparison of Chinese Patients With the Same or Similar Mutations in the LDL Receptor Gene in China or Canada. Arterioscler. Thromb. Vasc. Bio. 18: 309-315 [Abstract] [Full Text]  
• KOONER, J. S (1997). Coronary heart disease in UK Indian Asians: the potential for reducing mortality. Heart 78: 530-532 [Full Text]  
• Mijatovic, V., Kenemans, P., Netelenbos, J. C., Peters-Muller, E. R. A., van Kamp, G. J., Voetberg, G. A., van de Weijer, P. H. M., van der Mooren, M. J. (1997). Oral 17{beta}-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women. J. Clin. Endocrinol. Metab. 82: 3543-3547 [Abstract] [Full Text]  
• Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R. (1997). Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio. 17: 2783-2792 [Abstract] [Full Text]  
• Vuorio, A. F., Turtola, H., Piilahti, K.-M., Repo, P., Kanninen, T., Kontula, K. (1997). Familial Hypercholesterolemia in the Finnish North Karelia : A Molecular, Clinical, and Genealogical Study. Arterioscler. Thromb. Vasc. Bio. 17: 3127-3138 [Abstract] [Full Text]  
• Kang, C., Durlach, V., Soulat, T., Fournier, C., Angles-Cano, E. (1997). Lipoprotein(a) Isoforms Display Differences in Affinity for Plasminogen-Like Binding to Human Mononuclear Cells. Arterioscler. Thromb. Vasc. Bio. 17: 2036-2043 [Abstract] [Full Text]  
• Tonstad, S., Refsum, H., Ueland, P. M. (1997). Association Between Plasma Total Homocysteine and Parental History of Cardiovascular Disease in Children With Familial Hypercholesterolemia. Circulation 96: 1803-1808 [Abstract] [Full Text]  
• Hegele, R. A., Breckenridge, W. C., Brunt, J. H., Connelly, P. W. (1997). Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration. Arterioscler. Thromb. Vasc. Bio. 17: 1701-1706 [Abstract] [Full Text]  
• Nowak-Gottl, U., Debus, O., Findeisen, M., Kassenbohmer, R., Koch, H. G., Pollmann, H., Postler, C., Weber, P., Vielhaber, H. (1997). Lipoprotein (a): Its Role in Childhood Thromboembolism. Pediatrics 99: e11-e11 [Abstract] [Full Text]  
• Dugi, K. A., Feuerstein, I. M., Hill, S., Shih, J., Santamarina-Fojo, S., Jr, H. B. B., Hoeg, J. M. (1997). Lipoprotein Lipase Correlates Positively and Hepatic Lipase Inversely With Calcific Atherosclerosis in Homozygous Familial Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 17: 354-364 [Abstract] [Full Text]  
• Nickenig, G., Sachinidis, A., Michaelsen, F., Bohm, M., Seewald, S., Vetter, H. (1997). Upregulation of Vascular Angiotensin II Receptor Gene Expression by Low-Density Lipoprotein in Vascular Smooth Muscle Cells. Circulation 95: 473-478 [Abstract] [Full Text]  
• Kronenberg, F., Trenkwalder, E., Dieplinger, H., Utermann, G. (1996). Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time: Why Epidemiological Studies Might Fail. Arterioscler. Thromb. Vasc. Bio. 16: 1568-1572 [Abstract] [Full Text]  
• Sunayama, S., Daida, H., Mokuno, H., Miyano, H., Yokoi, H., Lee, Y. J., Sakurai, H., Yamaguchi, H. (1996). Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age. Circulation 94: 1263-1268 [Abstract] [Full Text]  
• van Kooten, F., van Krimpen, J., Dippel, D. W.J., Hoogerbrugge, N., Koudstaal, P. J. (1996). Lipoprotein(a) in Patients With Acute Cerebral Ischemia. Stroke 27: 1231-1235 [Abstract] [Full Text]  
• Gries, A., Gries, M., Wurm, H., Kenner, T., Ijsseldijk, M., Sixma, J. J., Kostner, G. M. (1996). Lipoprotein(a) Inhibits Collagen-Induced Aggregation of Thrombocytes. Arterioscler. Thromb. Vasc. Bio. 16: 648-655 [Abstract] [Full Text]  
• Duggirala, R., Villalpando, C. G., O'Leary, D. H., Stern, M. P., Blangero, J. (1996). Genetic Basis of Variation in Carotid Artery Wall Thickness. Stroke 27: 833-837 [Abstract] [Full Text]  
• O'Brien, K. D., Reichenbach, D. D., Marcovina, S. M., Kuusisto, J., Alpers, C. E., Otto, C. M. (1996). Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of `Degenerative' Valvular Aortic Stenosis. Arterioscler. Thromb. Vasc. Bio. 16: 523-532 [Abstract] [Full Text]  
• Schreiner, P. J., Heiss, G., Tyroler, H.A., Morrisett, J. D., Davis, C.E., Smith, R. (1996). Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness : The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Bio. 16: 471-478 [Abstract] [Full Text]  
• Margaglione, M., DiMinno, G., Grandone, E., Celentano, E., Vecchione, G., Cappucci, G., Grilli, M., Mancini, F. P., Postiglione, A., Panico, S., Mancini, M. (1996). Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward : Discrimination Between Individuals With and Without a History of IschemicStroke. Arterioscler. Thromb. Vasc. Bio. 16: 120-128 [Abstract] [Full Text]  
• Carmena, R., Lussier-Cacan, S., Roy, M., Minnich, A., Lingenhel, A., Kronenberg, F., Davignon, J. (1996). Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect. Arterioscler. Thromb. Vasc. Bio. 16: 129-136 [Abstract] [Full Text]  
• Jurgens, G., Taddei-Peters, W. C., Koltringer, P., Petek, W., Chen, Q., Greilberger, J., Macomber, P. F., Butman, B. T., Stead, A. G., Ransom, J. H. (1995). Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype Correlate With Severity and Presence of Ischemic Cerebrovascular Disease. Stroke 26: 1841-1848 [Abstract] [Full Text]  
• Galle, J., Bengen, J., Schollmeyer, P., Wanner, C. (1995). Impairment of Endothelium-Dependent Dilation in Rabbit Renal Arteries by Oxidized Lipoprotein(a) : Role of Oxygen-Derived Radicals. Circulation 92: 1582-1589 [Abstract] [Full Text]  
• Nielsen, L. B., Nordestgaard, B. G., Stender, S., Niendorf, A., Kjeldsen, K. (1995). Transfer of Lipoprotein(a) and LDL Into Aortic Intima in Normal and in Cholesterol-Fed Rabbits. Arterioscler. Thromb. Vasc. Bio. 15: 1492-1502 [Abstract] [Full Text]  
• Tonstad, S., Leren, T. P., Sivertsen, M., Ose, L. (1995). Determinants of Lipid Levels Among Children With Heterozygous Familial Hypercholesterolemia in Norway. Arterioscler. Thromb. Vasc. Bio. 15: 1009-1014 [Abstract] [Full Text]  
• Ferrieres, J., Lambert, J., Lussier-Cacan, S., Davignon, J. (1995). Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation. Circulation 92: 290-295 [Abstract] [Full Text]  
• Moliterno, D. J., Jokinen, E. V., Miserez, A. R., Lange, R. A., Willard, J. E., Boerwinkle, E., Hillis, L. D., Hobbs, H. H. (1995). No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans. Arterioscler. Thromb. Vasc. Bio. 15: 850-855 [Abstract] [Full Text]  
• van Roggen, J.F. G., van der Westhuyzen, D.R., Coetzee, G.A., Marais, A.D., Steyn, K., Langenhoven, E., Kotze, M.J. (1995). FH Afrikaner-3 LDL Receptor Mutation Results in Defective LDL Receptors and Causes a Mild Form of Familial Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 15: 765-772 [Abstract] [Full Text]  
• Valentine, R. J. (1992). Lipoprotein(a): A New Risk Factor for Vascular Disease. PERSPECT VASC SURG ENDOVASC THER 5: 84-99